nach oben

Journal of Clinical Immunology

Erschienen in:

01.07.2009

NF-κB Signaling in the Aging Process

verfasst von: Antero Salminen, Kai Kaarniranta

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The aging process represents a progressive decline in cellular and organism function. Explaining the aging process has given rise to a cornucopia for different theories in which the basic difference has been the question whether aging is genetically regulated or an entropic degeneration process.

Discussion

Different screening techniques have revealed that mammalian aging is associated with the activation of NF-κB transcription factor system. The NF-κB system is an ancient host defense system concerned with immune responses and different external and internal dangers, such as oxidative and genotoxic stress. NF-κB signaling is not only the master regulator of inflammatory responses but can also regulate several homeostatic responses such as apoptosis, autophagy, and tissue atrophy. We will describe how chronic activation of NF-κB signaling has the capacity to induce the senescent phenotype associated with aging. Interestingly, several longevity genes such as SIRT1, SIRT6, and FoxOs can clearly suppress NF-κB signaling and in this way delay the aging process and extend lifespan.

Conclusion

It seems that the aging process is an entropic degeneration process driven by NF-κB signaling. This process can be regulated by a variety of longevity genes along with a plethora of other factors such as genetic polymorphism, immune and dietary aspects, and environmental insults.

Troen BR. The biology of aging. Mt Sinai J Med. 2003;70:3–22.PubMed

Finch CE, Ruvkun G. The genetics of aging. Annu Rev Genomics Hum Genet. 2001;2:435–62. doi:10.1146/annurev.genom.2.1.435.PubMedCrossRef

Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-κB signaling is the culprit of inflamm-aging. Ageing Res Rev. 2008;7:83–105. doi:10.1016/j.arr.2007.09.002.PubMedCrossRef

Hayflick L. Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both. PLoS Genet. 2007;3:e220. doi:10.1371/journal.pgen.0030220.PubMedCrossRef

Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D, et al. The genetics of human longevity. Ann N Y Acad Sci. 2006;1067:252–63. doi:10.1196/annals.1354.033.PubMedCrossRef

Warner HR. Longevity genes: from primitive organisms to humans. Mech Ageing Dev. 2005;126:235–42. doi:10.1016/j.mad.2004.08.015.PubMedCrossRef

Smith ED, Kennedy BK, Kaeberlein M. Genome-wide identification of conserved longevity genes in yeast and worms. Mech Ageing Dev. 2007;128:106–11. doi:10.1016/j.mad.2006.11.017.PubMedCrossRef

Vijg J, Calder RB. Transcript of aging. Trends Genet. 2004;20:221–4. doi:10.1016/j.tig.2004.04.007.PubMedCrossRef

De Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009;25:875–81. doi:10.1093/bioinformatics/btp073.PubMedCrossRef

10.

Franceschi C, Valesin S, Bonafe M, Paolisso G, Yashin AI, Monti D, et al. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol. 2000;35:879–96. doi:10.1016/S0531-5565(00)00172-8.PubMedCrossRef

11.

Helenius M, Hanninen M, Lehtinen SK, Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB. Biochem J. 1996;318:603–8.PubMed

12.

Helenius M, Hanninen M, Lehtinen SK, Salminen A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol. 1996;28:487–98. doi:10.1006/jmcc.1996.0045.PubMedCrossRef

13.

Korhonen P, Helenius M, Salminen A. Age-related changes in the regulation of transcription factor NF-κB in rat brain. Neurosci Lett. 1997;225:61–4. doi:10.1016/S0304-3940(97)00190-0.PubMedCrossRef

14.

Helenius M, Kyrylenko S, Vehvilainen P, Salminen A. Characterization of aging-associated up-regulation of constitutive nuclear factor-κB binding activity. Antioxid Redox Signal. 2001;3:147–56. doi:10.1089/152308601750100669.PubMedCrossRef

15.

Roy AK, Vellanoweth RL, Chen S, Supakar PC, Jung MH, Song CS, et al. The evolutionary tangle of aging, sex, and reproduction and an experimental approach to its molecular dissection. Exp Gerontol. 1996;31:83–94. doi:10.1016/0531-5565(95)00020-8.PubMedCrossRef

16.

Spencer NFL, Poynter ME, Im SY, Daynes RA. Constitutive activation of NF-κB in an animal model of aging. Int Immunol. 1997;9:1581–8. doi:10.1093/intimm/9.10.1581.PubMedCrossRef

17.

Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998;273:32833–41. doi:10.1074/jbc.273.49.32833.PubMedCrossRef

18.

Kim HJ, Kim KW, Yu BP, Chung HY. The effect of age on cyclooxygenase-2 gene expression: NF-κB activation and IκBα degradation. Free Radic Biol Med. 2000;28:683–92. doi:10.1016/S0891-5849(99)00274-9.PubMedCrossRef

19.

Giardina C, Hubbard AK. Growing old with nuclear factor-κB. Cell Stress Chaperones. 2002;7:207–12. doi:10.1379/1466-1268(2002)007<0207:GOWNFB>2.0.CO;2.PubMedCrossRef

20.

Gosselin K, Abbadie C. Involvement of Rel/NF-κB transcription factors in senescence. Exp Gerontol. 2003;38:1271–83. doi:10.1016/j.exger.2003.09.007.PubMedCrossRef

21.

Adler AS, Sinha S, Kawahara TLA, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007;21:3244–57. doi:10.1101/gad.1588507.PubMedCrossRef

22.

Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705–16. doi:10.1016/0092-8674(86)90346-6.PubMedCrossRef

23.

Chen LF, Greene W. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol. 2004;5:392–401. doi:10.1038/nrm1368.PubMedCrossRef

24.

Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18:2195–224. doi:10.1101/gad.1228704.PubMedCrossRef

25.

Scheidereit C. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene. 2006;25:6685–705. doi:10.1038/sj.onc.1209934.PubMedCrossRef

26.

Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol. 2007;8:49–62. doi:10.1038/nrm2083.PubMedCrossRef

27.

Sebban H, Yamaoka S, Courtois G. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling. Trends Cell Biol. 2006;16:569–77. doi:10.1016/j.tcb.2006.09.004.PubMedCrossRef

28.

Janssens S, Tschopp J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ. 2006;13:773–84. doi:10.1038/sj.cdd.4401843.PubMedCrossRef

29.

Salminen A, Suuronen T, Huuskonen J, Kaarniranta K. NEMO shuttle: a link between DNA damage and NF-κB activation in progeroid syndromes? Biochem Biophys Res Commun. 2008;367:715–8. doi:10.1016/j.bbrc.2007.11.189.PubMedCrossRef

30.

Schreck R, Albermann K, Baeuerle PA. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992;17:221–37. doi:10.3109/10715769209079515.PubMedCrossRef

31.

Harman D. Free radical theory of aging. Mutat Res. 1992;275:257–66.PubMed

32.

Martin GM, Austad SN, Johnson TE. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet. 1996;13:25–34. doi:10.1038/ng0596-25.PubMedCrossRef

33.

Gloire G, Legrand-Poels S, Piette JNF. κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006;72:1493–505. doi:10.1016/j.bcp.2006.04.011.PubMedCrossRef

34.

Wuerzberger-Davis SM, Nakamura Y, Seufzer BJ, Miyamoto SNF. κB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene. 2007;26:641–51. doi:10.1038/sj.onc.1209815.PubMedCrossRef

35.

Rabe JH, Mamelak AJ, McElgunn PJS, Morison WL, Sauder DN. Photoaging: mechanisms and repair. J Am Acad Dermatol. 2006;55:1–19. doi:10.1016/j.jaad.2005.05.010.PubMedCrossRef

36.

Tanaka K, Hasegawa J, Asamitsu K, Okamoto T. Prevention of the ultraviolet B-mediated skin photoaging by a nuclear factor κB inhibitor, parthenolide. J Pharmacol Exp Ther. 2005;315:624–30. doi:10.1124/jpet.105.088674.PubMedCrossRef

37.

Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7:179–90. doi:10.1038/nri2038.PubMedCrossRef

38.

Danilova N. The evolution of immune mechanisms. J Exp Zool. 2006;306B:496–520.CrossRef

39.

Friedman R, Hughes AL. Molecular evolution of the NF-kappaB signaling system. Immunogenet. 2002;53:964–74. doi:10.1007/s00251-001-0399-3.CrossRef

40.

Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5. doi:10.1189/jlb.0306164.PubMedCrossRef

41.

Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev. 2000;173:89–97. doi:10.1034/j.1600-065X.2000.917309.x.PubMedCrossRef

42.

Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease. Amyloid-ß oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol. 2009;87:181–94. doi:10.1016/j.pneurobio.2009.01.001.PubMedCrossRef

43.

Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelek G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda). 2008;23:64–74. doi:10.1152/physiol.00040.2007.

44.

Caamano J, Hunter CANF. κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev. 2002;15:414–29. doi:10.1128/CMR.15.3.414-429.2002.PubMedCrossRef

45.

Liang Y, Zhou Y, Shen P. NF-κB and its regulation on the immune system. Cell Mol Immunol. 2004;5:343–50.

46.

Trebilcock GU, Ponnappan U. Nuclear factor κB induction in CD45RO+ and CD45RA+ T cell subsets during aging. Mech Ageing Dev. 1998;102:149–63.PubMedCrossRef

47.

Helenius M, Makelainen L, Salminen A. Attenuation of NF-κB signaling response to UVB light during cellular senescence. Exp Cell Res. 1999;248:194–202.PubMedCrossRef

48.

Huang MC, Liao JJ, Bonasera S, Longo DL, Goetzl EJ. Nuclear factor-κB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J. 2008;22:2142–50.PubMedCrossRef

49.

Sinclair DA, Guarente L. Extrachromosomal rDNA circles—a cause of aging in yeast. Cell. 1997;91:1033–42.PubMedCrossRef

50.

Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13:2570–80.PubMedCrossRef

51.

Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404:1–13.PubMedCrossRef

52.

Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature. 2006;444:868–74.PubMedCrossRef

53.

Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126:257–68.PubMedCrossRef

54.

Kwon HS, Ott M. The ups and downs of SIRT1. Trends Biochem Sci. 2008;33:517–25.PubMedCrossRef

55.

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23:2369–80.PubMedCrossRef

56.

Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 2007;292:L567–76.PubMedCrossRef

57.

Kwon HS, Brent MM, Getachew R, Jayakumar P, Chen LF, Schnolzer M, et al. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe. 2008;3:158–67.PubMedCrossRef

58.

Lombard DB, Schwer B, Alt FW, Mostoslavsky R. SIRT6 in DNA repair, metabolism and ageing. J Intern Med. 2008;263:128–41.PubMed

59.

Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315–29.PubMedCrossRef

60.

Kawahara TLA, Michishita E, Adler AS, Damian M, Berber E, Lin M, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell. 2009;136:62–74.PubMedCrossRef

61.

Braeckman B, Vanfleteren JR. Genetic control of longevity in C. elegans. Exp Gerontol. 2007;42:90–8.PubMedCrossRef

62.

Burnell AM, Houthoofd K, O'Hanlon K, Vanfleteren JR. Alternate metabolism during the dauer stage of the nematode Caenorhabditis elegans. Exp Gerontol. 2005;40:850–6.PubMedCrossRef

63.

Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24:7410–25.PubMedCrossRef

64.

Coffer PJ, Burgering BMT. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol. 2004;4:889–99.PubMedCrossRef

65.

Peng SL. Foxo in the immune system. Oncogene. 2008;27:2337–44.PubMedCrossRef

66.

Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity. 2004;21:203–13.PubMedCrossRef

67.

Lee HY, Youn SW, Kim JY, Park KW, Hwang CI, Park WY, et al. FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-κB. Arterioscler Thromb Vasc Biol. 2008;28:112–20.PubMedCrossRef

68.

Berdichevsky A, Viswanathan M, Horvitz HR, Guarente L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell. 2006;125:1165–77.PubMedCrossRef

69.

Salminen A, Ojala J, Huuskonen J, Kauppinen A, Suuronen T, Kaarniranta K. Interaction of aging-associated signaling cascades: inhibition of NF-κB signaling by longevity factors FoxOs and SIRT1. Cell Mol Life Sci. 2008;65:1049–58.PubMedCrossRef

70.

Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila Toll-Dorsal pathway. Annu Rev Cell Dev Biol. 1996;12:393–416.PubMedCrossRef

71.

Gauldie J. Inflammation and the aging process: devil or angel. Nutr Rev. 2007;65:S167–9.PubMedCrossRef

72.

Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007;65:S140–6.PubMedCrossRef

73.

Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol. 2005;37:1084–104.PubMedCrossRef

74.

Delano MJ, Moldawer LL. The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract. 2006;21:68–81.PubMedCrossRef

75.

Li H, Malhotra S, Kumar A. Nuclear factor-κB signaling in skeletal muscle atrophy. J Mol Med. 2008;86:1113–26.PubMedCrossRef

76.

Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HGW, et al. IKKß/NF-κB activation causes severe muscle wasting in mice. Cell. 2004;119:285–98.PubMedCrossRef

77.

Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399–412.PubMedCrossRef

78.

Wang E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp Geront. 1997;32:471–84.CrossRef

79.

Warner HR. Is cell death and replacement a factor in aging? Mech Age Dev. 2007;128:13–6.CrossRef

80.

Salminen A, Kaarniranta K. Regulation of the aging process by autophagy. Trends Mol Med. 2009 doi:10.1016/j.molmed.2009.03.004

81.

Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet. 2008;24:604–12.PubMedCrossRef

82.

Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-κB. Oncogene. 2006;25:6800–16.PubMedCrossRef

83.

Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci. 2004;117:5197–208.PubMedCrossRef

84.

Terman A, Brunk UT. Oxidative stress, accumulation of biological “garbage”, and aging. Antioxid Redox Signal. 2006;8:197–204.PubMedCrossRef

85.

Bergamini E, Cavallini G, Donati A, Gori Z. The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction. Ann NY Acad Sci. 2007;1114:69–78.PubMedCrossRef

86.

Dan HC, Baldwin AS. Differential involvement of IκB kinases α and ß in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt. J Immunol. 2008;180:7582–9.PubMed

87.

Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, Wei Y, et al. IKKß suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell. 2007;130:440–55.PubMedCrossRef

88.

Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA. 2008;105:3374–9.PubMedCrossRef

89.

Salminen A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J. Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci. 2008;65:2979–99.PubMedCrossRef

90.

Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol. 2002;54:453–72.PubMedCrossRef

91.

Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006;72:1439–52.PubMedCrossRef

92.

Mattson MP, Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 2006;29:632–9.PubMedCrossRef

93.

Rattan SI. Hormesis in aging. Ageing Res Rev. 2008;7:63–78.PubMedCrossRef

94.

Shakibaei M, Harikumar KB, Aggarwal BB. Resveratrol addiction: to die or not to die. Mol Nutr Food Res. 2009;53:115–28.PubMedCrossRef

95.

Keifer JA, Guttridge DC, Ashburner BP, Baldwin AS Jr. Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity. J Biol Chem. 2001;276:22382–7.PubMedCrossRef

96.

Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005;6:298–305.PubMedCrossRef

97.

Morgan TE, Wong AM, Finch CE. Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol. 2007;35:83–97.PubMed

98.

Weindruch R, Kayo T, Lee CK, Prolla TA. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J Nutr. 2001;131:918S–23S.PubMed

Titel: NF-κB Signaling in the Aging Process
verfasst von: Antero Salminen
Kai Kaarniranta
Publikationsdatum: 01.07.2009
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 4/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-009-9296-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Discussion

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Increased IgG Antibody-Induced Cytotoxicity Against Airway Epithelial Cells in Patients with Nonallergic Asthma

Effect of Arsenic on Regulatory T Cells

ICOS Deficiency Results in Exacerbated IL-17 Mediated Experimental Autoimmune Encephalomyelitis

Plasma 1,25 Dihydroxy Vitamin D3 Level and Expression of Vitamin D Receptor and Cathelicidin in Pulmonary Tuberculosis

Enhanced Expression of Transcription Factor GATA-4 in Inflammatory Bowel Disease and Its Possible Regulation by TGF-β1